Marissa B. Wilck

853 total citations
24 papers, 560 citations indexed

About

Marissa B. Wilck is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Marissa B. Wilck has authored 24 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 5 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Marissa B. Wilck's work include Pneumonia and Respiratory Infections (8 papers), Herpesvirus Infections and Treatments (6 papers) and Respiratory viral infections research (5 papers). Marissa B. Wilck is often cited by papers focused on Pneumonia and Respiratory Infections (8 papers), Herpesvirus Infections and Treatments (6 papers) and Respiratory viral infections research (5 papers). Marissa B. Wilck collaborates with scholars based in United States, Israel and Netherlands. Marissa B. Wilck's co-authors include Richard A. Zuckerman, Amelia Langston, Mohamed A. Kharfan‐Dabaja, Richard T. Kenney, Alice Chu, Mary K. Wloch, Larry Smith, Michael Boeckh, Alain Rolland and Lindsey R. Baden and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Marissa B. Wilck

22 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marissa B. Wilck United States	11	390	141	123	110	91	24	560
David Shasha Israel	13	157 0.4×	213 1.5×	85 0.7×	71 0.6×	64 0.7×	27	481
Tomohiko Koibuchi Japan	19	334 0.9×	333 2.4×	299 2.4×	322 2.9×	126 1.4×	56	950
Joseph Kuo United States	13	265 0.7×	94 0.7×	81 0.7×	51 0.5×	100 1.1×	27	494
C L Ingham Clark United Kingdom	11	326 0.8×	64 0.5×	144 1.2×	137 1.2×	135 1.5×	36	702
Massimiliano Secchi Italy	13	185 0.5×	367 2.6×	94 0.8×	95 0.9×	116 1.3×	20	684
Collin R. Diedrich United States	11	400 1.0×	489 3.5×	169 1.4×	126 1.1×	79 0.9×	13	657
Giancarlo Basaglia Italy	13	113 0.3×	88 0.6×	252 2.0×	64 0.6×	132 1.5×	32	641
Pierre‐Alain Rubbo France	13	285 0.7×	204 1.4×	80 0.7×	76 0.7×	30 0.3×	26	450
Abeer Moanna United States	11	208 0.5×	309 2.2×	101 0.8×	66 0.6×	50 0.5×	20	536
Mary Rinki United States	10	654 1.7×	181 1.3×	292 2.4×	62 0.6×	32 0.4×	10	893

Countries citing papers authored by Marissa B. Wilck

Since Specialization

Citations

This map shows the geographic impact of Marissa B. Wilck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marissa B. Wilck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marissa B. Wilck more than expected).

Fields of papers citing papers by Marissa B. Wilck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marissa B. Wilck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marissa B. Wilck. The network helps show where Marissa B. Wilck may publish in the future.

Co-authorship network of co-authors of Marissa B. Wilck

This figure shows the co-authorship network connecting the top 25 collaborators of Marissa B. Wilck. A scholar is included among the top collaborators of Marissa B. Wilck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marissa B. Wilck. Marissa B. Wilck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guerra, Andrea, et al.. (2024). A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016). Human Vaccines & Immunotherapeutics. 20(1). 2310900–2310900. 1 indexed citations

Wilck, Marissa B., Shaun Barnabas, Kulkanya Chokephaibulkit, et al.. (2023). A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV. AIDS. 37(8). 1227–1237. 2 indexed citations

Wilck, Marissa B., Oliver A. Cornely, Catherine Cordonnier, et al.. (2023). A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM). Clinical Infectious Diseases. 77(8). 1102–1110. 6 indexed citations

Zhang, Ying, et al.. (2022). Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously. Human Vaccines & Immunotherapeutics. 18(5). 2073747–2073747. 1 indexed citations

Bili, Androniki, Scott Dobson, Wanatpreeya Phongsamart, et al.. (2022). A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION). Vaccine. 41(3). 657–665. 10 indexed citations

Wilck, Marissa B., Zemin Xu, Jon E. Stek, Michelle G. Goveia, & Andrew W. Lee. (2021). Protective immune responses against Haemophilus influenzae type b elicited by a fully-liquid DTaP-IPV-Hib-HepB vaccine (VAXELIS™). Vaccine. 39(9). 1428–1434. 4 indexed citations

Wilck, Marissa B., Zemin Xu, Jon E. Stek, & Andrew W. Lee. (2020). Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants. Human Vaccines & Immunotherapeutics. 17(1). 191–196. 8 indexed citations

Schneeweiß, Sebastian, Peggy L. Carver, Kausik Datta, et al.. (2019). Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals. Journal of Antimicrobial Chemotherapy. 75(1). 221–228. 5 indexed citations

Myers, Jennifer C., et al.. (2017). A Case of Cavitary Pulmonary Mycobacterium Avium Intracellulare Infection in the Setting of Leflunomide Treatment. JCR Journal of Clinical Rheumatology. 23(4). 231–232.

10.

Mills, John, Marissa B. Wilck, Paige M. Porrett, et al.. (2016). Successful treatment of a disseminated infection with extensively drug‐resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin‐based multidrug regimen. Transplant Infectious Disease. 18(5). 777–781. 13 indexed citations

11.

Schneeweiß, Sebastian, Peggy L. Carver, Kausik Datta, et al.. (2016). Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort study. Journal of Antimicrobial Chemotherapy. 71(10). 2938–2944. 13 indexed citations

12.

Forrestel, Amy, Badri Modi, Sarah Longworth, Marissa B. Wilck, & Robert G. Micheletti. (2016). Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod. JAMA Neurology. 73(3). 355–355. 39 indexed citations

13.

Wilck, Marissa B. & Richard A. Zuckerman. (2013). Herpes Simplex Virus in Solid Organ Transplantation. American Journal of Transplantation. 13. 121–127. 33 indexed citations

14.

Lee, Lara Wine, Sara C. Keller, Marissa B. Wilck, Stephen J. Gluckman, & Abby S. Van Voorhees. (2013). From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis. Journal of the American Academy of Dermatology. 69(6). 1003–1013. 51 indexed citations

15.

Walsh, Stephen R., Marissa B. Wilck, Shringkhala Bajimaya, et al.. (2013). Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial. The Journal of Infectious Diseases. 207(12). 1888–1897. 56 indexed citations

16.

Kharfan‐Dabaja, Mohamed A., Michael Boeckh, Marissa B. Wilck, et al.. (2012). A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases. 12(4). 290–299. 171 indexed citations

17.

Seaman, Michael S., Marissa B. Wilck, Lindsey R. Baden, et al.. (2010). Effect of Vaccination with Modified Vaccinia Ankara (ACAM3000) on Subsequent Challenge with Dryvax. The Journal of Infectious Diseases. 201(9). 1353–1360. 26 indexed citations

18.

Wilck, Marissa B., Michael S. Seaman, Lindsey R. Baden, et al.. (2010). Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration. The Journal of Infectious Diseases. 201(9). 1361–1370. 55 indexed citations

19.

Wilck, Marissa B. & Lindsey R. Baden. (2008). Vaccination after stem cell transplant: a review of recent developments and implications for current practice. Current Opinion in Infectious Diseases. 21(4). 399–408. 8 indexed citations

20.

Wilck, Marissa B., et al.. (2001). Endocarditis Caused by Culture-Negative Organisms Visible by Brown and Brenn Staining: Utility of PCR and DNA Sequencing for Diagnosis. Journal of Clinical Microbiology. 39(5). 2025–2027. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact